SAENGER BRADLEY (Chief Financial Officer) reported 1 transaction at TONIX PHARMACEUTICALS HOLDING CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 2/27/2025ACC: 0001839882-25-011958
Officer· Chief Financial Officer
Since Feb 2026
+51.58K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
51.58K acquired · 0.04 disposed
Non-Derivative Transactions1
Common Stock, par value $0.001
Direct
Shares
−0.04
Price / share
—
Trade value
—
% of position
New position
2/5/2025
0.04→0.00
Total
Net shares
−0.04
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 Direct | 2/5/2025 | J · J | −0.04 | — | — | New position | 0.04 | 0.00 |
| Total | −0.04 | $0.00 | ||||||
Derivative Transactions2
Stock Option
Direct
Converts to
Common Stock
25.79K shares
Shares
+25.79K
Strike price
8.05
Held after
25.79K
Exercisable
—
2/25/2025
Stock Option
Direct
Converts to
Common Stock
25.79K shares
Shares
+25.79K
Strike price
10.0625
Held after
25.79K
Exercisable
—
2/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock25.79K shares | 2/25/2025 | A · Award | +25.79K | 8.05 | — | 25.79K |
| Stock Option Direct | Common Stock25.79K shares | 2/25/2025 | A · Award | +25.79K | 10.0625 | — | 25.79K |